News ArchivesRead News
Roundup herbicide linked to Parkinson’s-related brain damage
Tuesday April 24, 2012
Digital Journal - Monsanto's controversial herbicide, Roundup, has now been linked to Parkinsonism related disorders according to research reported in the Neurotoxicology & Teratology journal.
This month a new and alarming study has been published in the journal Neurotoxicology and Teratology which supports the emerging connection between glyphosate, Roundup's active ingredient, and the emergence of neurodegenerative conditions including Parkinson's disease and Parkinsonian disorders.
The new study, entitled "Glyphosate induced cell death through apoptotic and authophagic mechanisms," was arranged to investigate potential brain-damaging effects of herbicides which authors of the study stated "have been recognized as the main environmental factor associated with neurodegenerative disorders, such as Parkinson’s disease."
With the current wide use of Roundup herbicide in the U.S.A., it is considered to be a contaminant in air, groundwater, rain and food, making it virtually impossible to avoid.
Researchers in the new study found that glyphosate inhibited the viability of differentiated test cells (PC12, adrenal medula derived), in both dose-and-time dependent manners. They also discovered "glyphosate induced cell death via authophagy pathways in addition to activating apoptotic pathways."
There is a growing body of experimental evidence which indicates that besides its neurotoxicity, Roundup also has the following modes of toxicity:
Monsanto, the original patent holder and manufacturer of Roundup, once marketed the herbicide as "safe as table salt". However, evidence now points to the fact that it is toxic to human DNA, even at concentrations diluted 450-fold lower than those used in agricultural applications.
The current study only adds to the case reports of glyphosate poisoning and also occupational exposure in which neurological damage was a direct consequence.
In 2011 a case study was published in the journal Parkinsonism Related Disorders, entitled "Parkinsonism after chronic occupational exposure to glyphosate,"
In the report the following incident was quoted:
Here we report a patient with parkinsonism following chronic occupational exposure to glyphosate. A previously healthy 44-year-old woman presented with rigidity, slowness and resting tremor in all four limbs with no impairment of short-term memory, after sustaining long term chemical exposure to glyphosate for 3 years as a worker in a chemical factory. The chemical plant produced a range of herbicides including: glyphosate, gibberellins, and dimethyl hydrogen phosphite; however, the patient worked exclusively in the glyphosate production division. She only wore basic protection such as gloves or a face mask for 50 h each week in the plant where glyphosate vapor was generated. She frequently felt weak. Two months before she came to our clinic, she had experienced severe dizziness and blurred vision.
A further study which was published in 2003 also reported a case of Parkinsonism subsequent to glyphosate exposure.
The case studies have also been backed up with animal research. In a study using the roundworm (Caenorhabditis elegans) model of glyphosate exposure, the chemical results in neurodegeneration directly associated with damage to the dopamine and GABA producing neurons.
In the rat model case studies, published in 2005, it was found that glyphosate exposure results in oxidative brain damage, particularly the substantia nigra, where the highest concentration of dopamine-producing cells reside, and which is the primary locus of neurological damage in Parkinson’s disease.
Glyphosate exposure is now significant, with 88,000 tons used in the U.S.A. in 2007 alone. Add to this the likely billions of pounds used worldwide, this is now a serious matter indeed. There is accumulating evidence to indicate that glyphosate is resistant to biodegradation and in the areas where it has been applied, now contaminates the air, rain and groundwater.
Recent NewsNov 17 - 'Moving Day' participant is not letting young-onset Parkinson's disease stop him
Nov 17 - Focused ultrasound shows promise for treating Parkinson's tremor
Nov 17 - New research to target air pollution as a potential trigger for Parkinson’s
Nov 17 - This device will let you feel what it's like to suffer from Parkinson's
Nov 10 - How does Parkinson's disease influence depression?
Nov 10 - House votes to repeal ObamaCare's Medicare cost-cutting board
Nov 10 - Microsoft shows off watch that quiets Parkinson's tremors
Nov 3 - Utah group battling Parkinson's disease with boxing
Nov 3 - UVA-LED STUDY EXAMINES POTENTIAL OF SOUND WAVES TO MANAGE PARKINSON’S DISEASE
Oct 27 - Herbicide's link to Parkinson's disease
Oct 27 - NTU Singapore, KAIST scientists discover new mechanism that causes Parkinsonian symptoms
Oct 27 - 70,000 Washingtonians face higher insurance costs after Trump order, officials say
Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 18 - Fighting Parkinson's disease through dance
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests